Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantation

Autor: Peter Wenaweser, Bernhard Meier, Ahmed A. Khattab, Thierry Carrel, Christoph Huber, Thomas Pilgrim, Thomas Zanchin, Lutz Buellesfeld, Stephan Zbinden, Anne Bütikofer, Crochan J. O'Sullivan, Stephan Windecker, Stefan Stortecky, Stefan Blöchlinger, Fabien Praz, Dik Heg
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Male
medicine.medical_specialty
Cardiac Catheterization
Time Factors
animal structures
610 Medicine & health
Kaplan-Meier Estimate
macromolecular substances
Risk Assessment
Ventricular Function
Left

Risk Factors
360 Social problems & social services
Internal medicine
Cardiac Catheterization/adverse effects/methods/mortality
medicine
Clinical endpoint
Humans
Aortic Valve Stenosis/complications/diagnosis/mortality/physiopathology/therapy
Heart Valve Prosthesis Implantation/adverse effects/methods/mortality
Aged
Proportional Hazards Models
Aged
80 and over

Heart Valve Prosthesis Implantation
Mitral regurgitation
Ejection fraction
business.industry
Patient Selection
Hazard ratio
Mitral Valve Insufficiency
Stroke Volume
Aortic Valve Stenosis
medicine.disease
Mitral Valve Insufficiency/complications/diagnosis/mortality/physiopathology/therapy
Confidence interval
Surgery
Stenosis
Treatment Outcome
Concomitant
Aortic valve stenosis
Cardiology
cardiovascular system
Female
Cardiology and Cardiovascular Medicine
business
Switzerland
Zdroj: O'Sullivan, Crochan J; Stortecky, Stefan; Bütikofer, Anne; Heg, Dik; Zanchin, Thomas; Huber, Christoph; Pilgrim, Thomas; Praz, Fabien; Büllesfeld, Lutz; Khattab, Ahmed Aziz; Blöchlinger, Stefan; Carrel, Thierry; Meier, Bernhard; Zbinden, Stephan; Wenaweser, Peter Martin; Windecker, Stephan (2015). Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantation. Circulation: Cardiovascular interventions, 8(2), e001895. Lippincott Williams & Wilkins 10.1161/CIRCINTERVENTIONS.114.001895
Circulation. Cardiovascular Interventions, Vol. 8, No 2 (2015) P. e001895
ISSN: 1941-7640
DOI: 10.7892/boris.63518
Popis: Background— Up to 1 in 6 patients undergoing transcatheter aortic valve implantation (TAVI) present with low-ejection fraction, low-gradient (LEF-LG) severe aortic stenosis and concomitant relevant mitral regurgitation (MR) is present in 30% to 55% of these patients. The effect of MR on clinical outcomes of LEF-LG patients undergoing TAVI is unknown. Methods and Results— Of 606 consecutive patients undergoing TAVI, 113 (18.7%) patients with LEF-LG severe aortic stenosis (mean gradient ≤40 mm Hg, aortic valve area 2 , left ventricular ejection fraction P =0.76). At 1 year, LEF-LG patients with ≥moderate MR had an adjusted 3-fold higher rate of all-cause mortality (11.5% versus 38.1%; adjusted hazard ratio, 3.27 [95% confidence interval, 1.31–8.15]; P =0.011), as compared with LEF-LG patients with ≤mild MR. Mortality was mainly driven by cardiac death (adjusted hazard ratio, 4.62; P =0.005). As compared with LEF-LG patients with ≥moderate MR assigned to medical therapy, LEF-LG patients with ≥moderate MR undergoing TAVI had significantly lower all-cause mortality (hazard ratio, 0.38; 95% confidence interval, 0.019–0.75) at 1 year. Conclusions— Moderate or severe MR is a strong independent predictor of late mortality in LEF-LG patients undergoing TAVI. However, LEF-LG patients assigned to medical therapy have a dismal prognosis independent of MR severity suggesting that TAVI should not be withheld from symptomatic patients with LEF-LG severe aortic stenosis even in the presence of moderate or severe MR.
Databáze: OpenAIRE